Click a link below to view the mailing archive as if it had been sent to you.
| 2020-08-31 12:15 | | Nestle pays $2 billion to secure Aimmune’s allergy treatment and more... |
| 2020-08-31 00:15 | | Plan to expand global access to Covid-19 vaccines nears fish-or-cut-bait moment and more... |
| 2020-08-30 12:15 | | Moderna failed to disclose federal funding for vaccine patent applications, advocates say |
| 2020-08-30 00:15 | | Moderna in Talks to Sell 40 Million Coronavirus Vaccine Doses to Japan and more... |
| 2020-08-28 12:15 | | Why Novavax's Coronavirus Vaccine Might Be First to Market and more... |
| 2020-08-28 00:15 | | Athira Aims for the Nasdaq to Advance Alzheimer’s Drug to Phase 2 Tests and more... |
| 2020-08-27 12:15 | | Phase 3 wins put Dermavant closer to filing Otezla rival tapinarof and more... |
| 2020-08-27 00:15 | | New Covid-19 testing guidelines, crafted at the White House, alarm public health experts and more... |
| 2020-08-26 12:15 | | Teva charged — again — for alleged role in fixing generic drug prices, this time by the Department of Justice and more... |
| 2020-08-26 00:15 | | Sarepta Therapeutics Gets Fast-Track FDA Review For Muscular Dystrophy Drug and more... |
| 2020-08-25 12:15 | | Exelixis Files for Cabometyx Combo in First-Line Kidney Cancer and more... |
| 2020-08-25 00:15 | | Novavax Starts Phase 2 Coronavirus Vaccine Clinical Trial and more... |
| 2020-08-24 12:15 | | Bristol Myers to buy Forbius in hunt for Opdivo-enhancing drugs and more... |
| 2020-08-24 00:15 | | FDA, under pressure from Trump, authorizes blood plasma as Covid-19 treatment and more... |
| 2020-08-23 00:15 | | Drug makers rebut Trump tweet that FDA ‘deep state’ is delaying Covid-19 vaccines and drugs and more... |
| 2020-08-22 00:15 | | Boehringer Ingelheim to Pay $379,000 to Settle Wage Discrimination Charges and more... |
| 2020-08-21 12:15 | | BioMarin (BMRN) Files NDA for Vosoritide to Treat Dwarfism |
| 2020-08-21 00:15 | | Novartis set to take on Roche as FDA clears first at-home, injectable MS drug and more... |
| 2020-08-20 12:15 | | Is valrox dead? and more... |
| 2020-08-20 00:15 | | Regeneron flashes ‘great advance' in the NEJM for that other cholesterol drug sitting at the FDA and more... |
| 2020-08-19 12:15 | | Accelerate Diagnostics Announces Emergency Use Authorization for Covid-19 Antibody Test and more... |
| 2020-08-19 00:15 | | How did Novo Nordisk's Sophia chatbot become a pharma industry standard? Empathy, timing and relevance: experts and more... |
| 2020-08-18 12:15 | | Pharma improves HCP engagement during COVID-19 – report and more... |
| 2020-08-18 00:15 | | Moderna stands to earn $300M for quick vaccine approval, up to $6.6B for extra doses: filing and more... |
| 2020-08-17 12:15 | | US will create new strain of coronavirus for vaccine development and more... |
| 2020-08-17 00:15 | | Pfizer's Unheralded Franchise That's Worth Billions of Dollars and more... |
| 2020-08-16 00:15 | | If You Invested $1,000 in Novavax's IPO, This Is How Much Money You'd Have Now and more... |
| 2020-08-15 00:15 | | Mesoblast scores FDA committee's backing for cell therapy despite some early worries |
| 2020-08-14 12:15 | | Viaskin™ Peanut’s Long-Term Phase III Updates and What the FDA Has to Say About Them and more... |
| 2020-08-14 00:15 | | On heels of U.S. pact, Johnson & Johnson strikes a double-size COVID vaccine deal with Europe and more... |
| 2020-08-13 12:15 | | Thermo Fisher's Qiagen takeover bid fails after target gets COVID testing boost and more... |
| 2020-08-13 00:15 | | FDA gives speedy approval to another Duchenne drug and more... |
| 2020-08-12 12:15 | | Mesoblast faces FDA pushback over cell therapy manufacturing, clinical data: documents and more... |
| 2020-08-12 00:15 | | Bayer inks $425M upfront KaNDy buyout to challenge Astellas for menopause market and more... |
| 2020-08-11 12:15 | | Pieris begins gastric cancer combination trial with Lilly’s Cyramza and more... |
| 2020-08-11 00:15 | | Gilead Sciences Submits New Drug Application for Remdesivir as a COVID-19 Treatment and more... |
| 2020-08-10 12:15 | | Sophia Genetics launches AI tool to find COVID-19 ‘unknowns’ and more... |
| 2020-08-10 00:15 | | WCLC: Lilly, Innovent tout Tyvyt front-line lung cancer win. Can it challenge Merck’s Keytruda? and more... |
| 2020-08-09 00:15 | | FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy and more... |
| 2020-08-07 12:15 | | Pfizer signs deal with Gilead to manufacture COVID-19 antiviral remdesivir and more... |
| 2020-08-07 00:15 | | Novo Nordisk axes experimental obesity drugs after success with later-stage meds and more... |
| 2020-08-06 12:15 | | AstraZeneca in first COVID-19 vaccine deal with Chinese company and more... |
| 2020-08-06 00:15 | | Say Hello To The Largest Virtual Care Company: The $38 Billion Teladoc-Livongo Merger and more... |
| 2020-08-05 12:15 | | Johnson & Johnson reaches deal with U.S. for 100 million doses of coronavirus vaccine at more than $1 billion and more... |
| 2020-08-05 00:15 | | Healthineers makes its ambition plain with $16.4bn Varian buy and more... |
| 2020-08-04 12:15 | | What's Behind Pacific Biosciences of California's Ugly Q2 Results? and more... |
| 2020-08-04 00:15 | | Novartis’ Ilaris unexpectedly slashes need for joint replacements from osteoarthritis in key study and more... |
| 2020-08-03 12:15 | | Lilly to test COVID-19 antibody drug in unorthodox nursing home study and more... |
| 2020-08-03 00:15 | | The 10 most expensive Part B drugs in 2018 and more... |
| 2020-08-01 00:15 | | Merck to Begin Pivotal COVID-19 Antiviral Studies in September and more... |
